| Particulars |
|
|
|
| Company Name
| Emcure Pharmaceuticals Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
189.71 |
B.V. (₹) |
195.60 |
| Sales(₹ Cr.) |
5,243.19 |
NP (₹ Cr.) |
751.96 |
| NP Var% |
180.00 |
Div% |
36.00 |
| CPS(₹) |
52.60 |
EPS (₹) |
39.60 |
| Traded Value(₹ Lakhs) |
703.68 |
52 Week High |
2,101.00 |
| 52 Week Low |
1,308.00 |
Price BSE |
1,983.00 |
| Price NSE |
1,977.00 |
Market Capital (₹ Cr.) |
37,611.08 |
| P/C Ratio |
37.70 |
P/E Ratio |
50.00 |
| Price Vs.BV |
10.14 |
|
| Latest Quarter |
| Year End |
202609 |
Sales (₹ Cr.) |
1,667.98 |
| NP(₹ Cr.) |
248.43 |
NP Var % |
111.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
3,847.63 |
| OPM |
13.27 |
NP |
232.25 |
| NP Var% |
105.90 |
EPS |
43.63 |
| PE |
45.44 |
|
|